WAM
ROIV icon

Wolverine Asset Management’s Roivant Sciences ROIV Stock Holding History

Wolverine Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-365
Closed -$3.68K – 1959
2023
Q2 		$3.68K Buy
+365
New +$3.27K ﹤0.01% 1512
2023
Q1 		– Sell
-822
Closed -$6.57K – 2055
2022
Q4 		$6.57K Buy
+822
New +$4.57K ﹤0.01% 1711
2022
Q2 		– Sell
-100
Closed – – 2444
2022
Q1 		$0 Buy
+100
New +$660 ﹤0.01% 2349

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wolverine Asset Management's ROIV Position: Q3 2023 in Review

Wolverine Asset Management sold out of Roivant Sciences (ROIV) in Q3 2023, closing a stake of 365 shares — an estimated $3.68K sold.

Wolverine Asset Management first reported a position in ROIV in Q1 2022 and held it in 3 quarters. The position peaked at $6.57K in Q4 2022. 205 funds tracked by Wall St. Rank hold ROIV as of Q3 2023.

  • Wolverine Asset Management reported no remaining Roivant Sciences position as of Q3 2023 after selling out during the quarter.
  • Wolverine Asset Management sold 365 Roivant Sciences shares in Q3 2023, an estimated $3.68K.
  • Wolverine Asset Management first reported a position in Roivant Sciences in Q1 2022 and held it in 3 quarters.
  • Wolverine Asset Management's Roivant Sciences position peaked at $6.57K in Q4 2022.
  • 205 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2023.

Based on Wolverine Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.